Approval of Complera: emtricitabine/rilpivirine/tenofovir DF fixed dose combination
Links shared publicly online about this topic.
- 80total visits
Approval of Complera: emtricitabine/rilpivirine/tenofovir DF fixed dose combination
fda.gov —
View full resource at fda.gov
Most Recently Shared on August 12, 2011 at 10:52 pm By:
Approval of Complera: Emtricitabine/Rilpivirine/Tenofovir DF Fixed Dose Combination: Source: Food and Drug Admin... http://t.co/kyOsxCH
Also Shared By:
Once-Daily Single-Tablet Complera For HIV-1 Infection Approved By FDA - QualityPoint Technologies
qualitypointtech.net — “The US FDA has approved Complera (emtricitabine/rilpivirine/tenofovir disoproxil fumarate), a once-a-day single tablet for patients with HIV-1 infection who are new to treatment (treatment-naïve patients), makers and marketers Gilead Sciences Inc. announced today. Complera contains three antiretroviral drugs in one tablet: Truvada - a Gilead medication, a fixed-dose combination of two medications, emtricitabine and tenofovir disoproxil fumarate. Approved by the FDA in August 2004...” View full resource at qualitypointtech.net
Most Recently Shared on August 11, 2011 at 1:45 am By:
Once-Daily Single-Tablet Complera For HIV-1 Infection Approved By FDA: The US FDA has approved Complera (emtricita... http://bit.ly/ozFQu6
Advertisement
Trish D'Antonio
@tdanton
HIV and AIDS Activities Approval of Complera: emtricitabine/rilpivirine/tenofovir DF fixed dose combination: http://t.co/BVRnb2W
1 year ago...